JP2025510556A5 - - Google Patents
Info
- Publication number
- JP2025510556A5 JP2025510556A5 JP2024552684A JP2024552684A JP2025510556A5 JP 2025510556 A5 JP2025510556 A5 JP 2025510556A5 JP 2024552684 A JP2024552684 A JP 2024552684A JP 2024552684 A JP2024552684 A JP 2024552684A JP 2025510556 A5 JP2025510556 A5 JP 2025510556A5
- Authority
- JP
- Japan
- Prior art keywords
- s1pr
- modulator
- disease
- alzheimer
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22166162.2A EP4252748A1 (en) | 2022-03-31 | 2022-03-31 | A sphingosine-1-phosphate receptor (s1pr) modulator for use in treating a patient suffering from alzheimer's dementia |
| EP22166162.2 | 2022-03-31 | ||
| PCT/EP2023/058360 WO2023187091A1 (en) | 2022-03-31 | 2023-03-30 | A sphingosine-1-phosphate receptor (s1pr) modulator for use in treating a patient suffering from alzheimer's dementia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510556A JP2025510556A (ja) | 2025-04-15 |
| JP2025510556A5 true JP2025510556A5 (enExample) | 2025-10-24 |
Family
ID=81325093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552684A Pending JP2025510556A (ja) | 2022-03-31 | 2023-03-30 | アルツハイマー型認知症に罹患している患者の治療において使用するためのスフィンゴシン－１－リン酸受容体（ｓ１ｐｒ）モジュレーター |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250325501A1 (enExample) |
| EP (2) | EP4252748A1 (enExample) |
| JP (1) | JP2025510556A (enExample) |
| CA (1) | CA3250398A1 (enExample) |
| WO (1) | WO2023187091A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120010264A1 (en) * | 2009-03-26 | 2012-01-12 | Dainippon Sumitomo Pharma Co., Ltd. | Novel medicament for treating cognitive impairment |
| DK3081568T3 (da) * | 2011-05-09 | 2020-02-24 | Eip Pharma Llc | Sammensætninger og fremgangsmåder til behandling af alzheimers sygdom |
| EP3193870A4 (en) * | 2014-09-16 | 2018-04-25 | Teva Pharmaceutical Industries Ltd. | Treatment of neurodegenerative diseases with combination of laquinimod and fingolimod |
| EP3621610A1 (en) * | 2017-05-08 | 2020-03-18 | Celgene International II Sàrl | Sphingosine 1 phosphate receptor agonists for neuroprotection |
| WO2019243453A1 (en) * | 2018-06-19 | 2019-12-26 | Universidad Pablo De Olavide | Compositions for treating and/or preventing protein-aggregation diseases |
-
2022
- 2022-03-31 EP EP22166162.2A patent/EP4252748A1/en not_active Ceased
-
2023
- 2023-03-30 WO PCT/EP2023/058360 patent/WO2023187091A1/en not_active Ceased
- 2023-03-30 US US18/852,464 patent/US20250325501A1/en active Pending
- 2023-03-30 CA CA3250398A patent/CA3250398A1/en active Pending
- 2023-03-30 JP JP2024552684A patent/JP2025510556A/ja active Pending
- 2023-03-30 EP EP23728596.0A patent/EP4499056A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100283709B1 (ko) | 안정한 서방성 경구 투여 조성물 | |
| US5859060A (en) | Timed release tablet comprising naproxen and pseudoepherine | |
| TW200815048A (en) | Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies | |
| AU703242B2 (en) | Film coated tablet of paracetamol and domperidone | |
| RU2298402C2 (ru) | Твердая лекарственная форма тербинафина для перорального введения | |
| JP4284017B2 (ja) | 固形製剤 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| BRPI0416702B1 (pt) | formulação purgativa colônica em uma forma de dosagem sólida para administração oral, e, kit | |
| JP2007302657A (ja) | 痙症の兆候および症候の緩和方法 | |
| ES2865278T3 (es) | Amantadina para mejorar la marcha en esclerosis múltiple | |
| JP5828609B2 (ja) | 持続性解熱鎮痛消炎剤 | |
| CN105338970A (zh) | 包含他达拉非和坦洛新的药物胶囊复合制剂 | |
| JP5542309B2 (ja) | 経口医薬組成物 | |
| US20100113453A1 (en) | Sublingual Formulations of D-Cycloserine and Methods of Using Same | |
| CN102805746A (zh) | 一种作用于呼吸系统疾病的复方化学药及其制备工艺与应用 | |
| BR112020003375A2 (pt) | composições de amantadina, preparações das mesmas, e métodos de uso | |
| JP2009242360A (ja) | 経口用の慢性疼痛予防または治療剤 | |
| CN108354898A (zh) | 一种治疗类风湿性关节炎的透皮给药制剂及其制备方法 | |
| CN101264080A (zh) | 一种含有右旋氯苯那敏的药用组合物及其制备方法 | |
| ES2286716T3 (es) | Composicion farmaceutica de liberacion controlada y proceso para preparar la misma. | |
| US8748489B2 (en) | Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent | |
| JPH05246845A (ja) | イブプロフェン含有解熱鎮痛剤 | |
| CN109922795A (zh) | 褪黑素小片剂及其制备方法 | |
| JPH04193823A (ja) | 噛み砕きやすく水なしで飲みやすい丸剤 | |
| TWI850283B (zh) | 用於治療糜爛性手部骨關節炎的孟魯司特 |